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Spontaneous DNA Damage, Minireview
Genome Instability, and Cancer—
When DNA Replication Escapes Control
myces cerevisiae. The objective of this article is to evalu-
ate these data and their possible implications for human
cancer.
Routes to Chromosomal Aberration
If we accept that an initial mutational event early in the
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history of a tumor increases the rate of chromosomal
instability, the question arises of what the possible ge-
netic culprits might be. The wide heterogeneity of gross
Human cancer can be viewed as a disease of underlying chromosomal aberrations associated with human tu-
genetic instability. Most, if not all human tumors dis- mors (Mitelman et al., 1994) suggests that a variety of
play some form of genomic instability, including subtle different cellular processes and, hence, a great number
DNA sequence alterations, gross chromosomal re- of genes might be affected. For simplicity, we can assign
arrangements, aneuploidy, and gene amplifications. two major categories of mechanistically distinct events:
These alterations have the potential to affect the func- those that simply affect chromosome numbers, and
tion of growth-regulating genes that are associated with those that alter chromosome structure. Chromosome
the malignant transformation of cells. Therefore, to un- number instabilities are found in most human malignan-
derstand the early events in tumor development, we cies and likely reflect malfunction of the mitotic chromo-
need to explore the origin of the genetic alterations that some segregation apparatus (Lengauer et al., 1998).
are typically found in human tumors. However, changes in chromosome structure are equally
The basis of genomic instability is unfaithful transmis- frequent and point to irregularities in DNA metabolic pro-
sion of genetic information from a cell to its daughters. cesses rather than in chromosome distribution. Since
This arises from failure of cellular functions that ensure these chromosomal aberrations usually involve breakage
the accuracy of DNA transactions such as DNA replica- and rejoining of DNA segments, the underlying cause
tion, DNA damage repair, or mitotic chromosome distri- seems to be related to either the generation or the repair
bution. Specific functional defects can be associated of DNA strand breaks. Studies in different models have
with a characteristic pattern of genomic instability. For established that treatment of cells with agents that in-
example, inactivation of functions that increase the fidelity duce DNA double-strand breaks (DSB’s) leads to recom-
of DNA replication or eliminate mutagenic DNA lesions binational repair and can give rise to chromosomal re-
enhances the rate of subtle DNA sequence alterations. arrangements (reviewed in Friedberg et al., 1995).
This is illustrated by the phenotypes of postreplicative Enhanced mitotic recombination also results from meta-
mismatch repair (MMR) or nucleotide excision repair bolic accumulation of DNA strand interruptions during
(NER) defects. Malfunction of MMR causes an increase lagging strand DNA synthesis in yeast and human cells
in spontaneous mutation rate, microsatellite DNA insta- with a defective DNA ligase I (Lindahl and Barnes, 1992).
bility, and a strong, heritable predisposition to cancer Similarly, defects in replication associated RecQ-like
(reviewed in Jiricny, 1998). Similarly, NER failure, such DNA helicases such as the Sgs1p of yeast or the homolo-
as in Xeroderma pigmentosum and related genetic dis- gous Bloom’s helicase (BLM) of human cells cause in-
orders, results in increased mutation rates induced by creased mitotic recombination and chromosomal insta-
UV and an increased risk of cancer (reviewed in de Boer bility (Frei and Gasser, 2000). These examples support
and Hoeijmakers, 2000). These specific genetic defects the principle that irregularities during DNA replication
in DNA surveillance illustrate that increasing the rate of can generate substrates for recombination and give rise
a particular form of genomic instability can contribute to gross chromosomal aberrations. In tumor cells, which
to the development of a tumor. However, the underlying usually evolve in the absence of external sources of DNA
damage, an enhanced rate of chromosomal instabilitycauses of the more dramatic gross chromosomal aber-
could thus be accounted for by either increased forma-rations that predominate in human cancers are less
tion of DNA strand breaks due to an endogenous DNAclear. An important question is whether the same princi-
metabolic defect or enhanced irregular repair of strandple applies, i.e., can connections be established be-
breaks that arise during DNA synthesis or excisiontween defined genetic defects that alter the rate of chro-
repair.mosomal aberrations and accelerated development of
Irregular repair of a DNA strand break can be definedtumors? Perhaps the most convincing argument to date
as the events that occur when its allocation to the appro-in favor of a genetic instability hypothesis is the karyo-
priate repair pathway fails. Allocation to the proper re-typic heterogeneity of most solid tumors (Mitelman et
pair system is not as trivial as it might seem, as theal., 1994), suggesting the persistent generation of novel
choice depends on where in the genome and in whichgenetic variants during tumor progression at an in-
physiological context strand breaks occur; i.e., a partic-creased rate. The paper by Myung et al. (2001) in this
ular DNA repair pathway may be appropriate (“regular”)issue of Cell provides evidence for a role of replication-
in one situation, but inappropriate (“irregular”) in an-associated DNA damage signaling in suppression of
other. For example, when a DSB arises at the site of aspontaneous chromosomal aberrations in Saccharo-
stalled replication fork during DNA synthesis, the S
phase cell recognizes and reacts to the problem. Homol-
ogous recombination may be utilized to repair the DSB* E-mail: schaer@imr.unizh.ch
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Figure 1. Options for Mutagenic and Nonmu-
tagenic Repair of an S Phase DNA Lesion
in the Presence or Absence of Regular DNA
Damage Signaling and Repair Pathways
Depicted is an example of a DNA DSB arising
during DNA replication. Damage signaling ei-
ther provides for coordinated repair by an
appropriate repair pathway (i.e., sister chro-
matid recombination) that restores the intact
chromosome or subjects the cell to pro-
grammed cell death (center). Both events pre-
serve genomic stability. If the regular repair
system is nonfunctional (right side), “irregu-
lar” pathways may gain access to the damage
and perform mutagenic repair (i.e., telomere
addition, translocations, and end-to-end liga-
tion), or damage signaling induces apoptosis.
If damage signaling fails (left), coordinated
repair of the DSB is disturbed and the option
for regular repair may be lost as the cell pro-
gresses in the cell cycle. Irregular repair
events then give rise to genomic instability.
using the sequence information from the unbroken sister in RFC5, MEC1, DDC2, DUN1, and PDS1 increase the
rate of chromosomal aberrations by more than two or-chromatid (Paulovich et al., 1997; Johnson and Jasin,
2000). If sister chromatid recombination is nonfunctional ders of magnitude, while mutations in MEC3, RAD53,
and CHK1 cause intermediate effects. DNA damagebecause of a mutation inactivating homologous recom-
bination, the cell can try to repair the damage through checkpoints controlled by RAD9, RAD17, and RAD24
appear to contribute only marginally to chromosomalalternative pathways (i.e., nonhomologous endjoining or
telomere addition) which, in this particular physiological stability in this assay, and mitotic checkpoint deficient
bub3 and mad3 mutants did not show any effect at all.context, are inappropriate and more error prone. Simi-
larly, if the DSB arises unnoticed because of a failure in RFC5 encodes a subunit of the replication factor C
that functions as a PCNA loader during DNA replicationdamage signaling, the cell passes on to later stages
of the cell cycle where the option of repair by sister and has also been implicated in signaling of replication
associated DNA damage. MEC1 encodes a member ofchromatid recombination may be lost. However, if the
cell is to survive, the DSB must be repaired. Homologous the subfamily of phospho-inositide kinase type protein
kinases (PI(3)K) that also includes the human ataxia tel-recombination between non-sister chromatids or ec-
topic regions would risk loss of heterozygosity or the angiectasia mutated (ATM) and ATR proteins. It acts as
a signal transducer in response to DNA damage andformation of chromosomal translocations. Nonhomolo-
gous end joining would increase the chance of chromo- phosphorylates a number of downstream signaling fac-
tors such as Ddc2, Rad53p, and Chk1p. Therefore, thesomal end-to-end ligation or of losing DNA sequence
information, and addition of a new telomere to the bro- common chromosomal instability phenotype of rfc5-1,
mec1, ddc2, and dun1 mutants suggests that key com-ken chromatid would lead to the loss of the fragment
distal to the DSB. This is just one possible scenario to ponents of an S phase DNA damage signaling pathway
constitute a system for suppression of spontaneousillustrate that “irregular repair” of a DSB can occur not
only when the appropriate pathway is nonfunctional, but chromosomal aberrations. However, there are some un-
certainties associated with this interpretation of the ge-also when the cellular DNA damage response is faulty
and the correct order of DNA repair and cell cycle pro- netic data. For example, Rfc5p is primarily a replication
protein. It is therefore unclear whether the increase ingression is disturbed (discussed in Paulovich et al.,
1997). The underlying principle of the “irregular repair” chromosomal aberrations in the rfc5-1 mutant is due to
a failure in DNA damage sensing or to a defect in DNAidea is depicted in Figure 1, and leads to the argument
that a failure in DNA damage signaling could be as harm- replication that generates DNA lesions. The same ap-
plies to other factors discussed in this context, includingful as a specific DNA repair defect, because it allows
mutagenic repair of DNA damage while lowering the Pol2p and Dpb11p, which are both essential subunits
of DNA polymerase e. Nevertheless, since the chromo-rate of apoptotic cell death. Consistent with this, most
human tumors not only display chromosomal instability somal aberration rates in rfc5-1 mec1 and rfc5-1 dun1
double mutants are not significantly different from thosebut also miss some checkpoints (reviewed in Hartwell
and Kastan, 1994). of either of the single mutants, the conclusion that the
rfc5-1 defect feeds into a DNA damage signaling path-Spontaneous DNA Damage, Failing Checkpoints,
and Chromosomal Instability way that involves Mec1p and Dun1p seems valid. The
observation that mec1 and dun1 mutants are more se-The data presented by Myung et al. (2001 [this issue
of Cell]) argue for a role of an S phase DNA damage verely affect in chromosomal stability than the rad53
mutant is incompatible with the current view that Mec1pcheckpoint in signaling of spontaneous DNA damage
and suppression of chromosomal aberrations in Sac- signals through Rad53p to Dun1p. However, the current
set of genetic data is too limited to provide strong sup-charomyces cerevisiae. The paper shows that mutations
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port for alternative models for functional interactions in ual DNA repair pathways. This might involve not only
Dun1p-, Rad53p-, and Chk1p-mediated processes butS phase checkpoint signaling.
The role of Pds1p is also not entirely clear. Pds1p was also a direct regulation of the Mre11p-Rad50p-Xrs2
complex. This heterotrimer, which has DNA binding andfirst identified as an anaphase inhibitor that responds to
DNA damage or malformation of mitotic spindles, but nuclease activity, has been implicated in various DNA
transactions, including DSB processing and recombina-has also been associated with a Mec1p-independent
late S phase checkpoint (Clarke et al., 1999). Mutation of tional repair, telomere silencing and maintenance, and
DNA damage signaling (Haber, 1998). This multifunc-PDS1 causes a chromosomal destabilization phenotype
comparable to that of rfc5 or mec1 mutants. The dra- tionality makes the Mre11 complex a potential mediator
at the interfaces between DNA damage sensing andmatic increase of chromosomal aberrations in the pds1
mec1 double mutant indicates that Mec1p and Pds1p signaling, and/or signaling and repair. The data from a
previous study (Chen and Kolodner, 1999) show that themay function in separate but partially redundant path-
ways for DNA damage signaling. However, the detailed Mre11 complex, but neither homologous recombination
nor nonhomologous end-joining, is necessary for chro-architecture of the relevant signaling pathways involved
remains to be resolved. mosome stability. Thus, the role of the Mre11 complex
in this context could be more closely associated withThe genetic assay used in this study selects for a
specific class of chromosomal aberration events: for transmission of DNA damage signals than with a direct
engagement in DSB repair processes. This is an attrac-deletions of nonessential telomeric regions located on
chromosomes V and VII (Chen and Kolodner, 1999). It tive possibility that warrants further investigation.
Checkpoint Failure, Chromosomal Instability,may therefore bias an assignment of characteristic pat-
terns of genomic rearrangements to specific DNA dam- and Cancer
To gain insight into the complex network of signal trans-age signaling defects. Nevertheless, in this particular
system, the predominant events caused by mutations duction pathways that monitor the state of DNA and
provide for genetic stability, we are forced to use simplein RFC5, MEC1, and DUN1 were deletions associated
with simple addition of new telomeres. In tel1 mutants, models that allow for a genetic and molecular dissection
of general principles and individual functions. The exam-however, which showed wild-type levels of chromo-
somal instability, telomere additions were totally sup- ple discussed above illustrates an approach with the
yeast model that suggests a connection between an Spressed. TEL1 encodes a Mec1p-related protein and
thus belongs to the family of ATM-related protein ki- phase checkpoint defect and a specific form of chromo-
somal instability. This is consistent with previous studiesnases. Its primary role is the control of telomere lengths,
but it has also been implicated in DNA damage signaling in yeast that have associated other cell cycle defects
with increased mitotic recombination and chromosomethrough phosphorylation of checkpoint factors such as
Rad9p and Rad53p. The finding that the loss of Tel1p nondisjunction (reviewed in Paulovich et al., 1997). What
is the broader significance of these observations withaffects the ability to add new telomeres to broken chro-
mosomes, but does not increase the rate of chromo- regard to the more complex situation in human cells?
Is there evidence for a causal relationship betweensomal aberrations suggests a function of this kinase
in telomere regulation, rather than in suppression of checkpoint failure, genomic instability, and cancer?
Studies of human cancer predisposition syndromes andchromosomal rearrangements through DNA damage
signaling. However, this seems to be true only as long mouse knockout models have revealed several connec-
tions between defects in DNA damage checkpointas the related Mec1p kinase is active. Inactivation of
Mec1p in a tel1 mutant increased the rate of chromo- genes and tumorigenesis. Well documented examples
are the ataxia telangiectasia mutated (ATM) gene,somal rearrangements synergistically, suggesting that
the two related protein kinases can partially substitute BRCA1 and BRCA2, the NBS1 gene, the BLM and WRN
genes mutated in patients with Bloom’s and Werner’sfor each other in signaling of spontaneous DNA damage
in S phase. syndrome, respectively, and, of course, p53. In all of
these cases, inactivating mutations cause defects inWhat does the study tell us about DNA damage signal-
ing? The source of DNA damage must be endogenous DNA damage signaling, give rise to some form of chro-
mosomal instability, and increase the risk of cancer.since the cells were not exposed to DNA-damaging con-
ditions. Also, since the major signaling pathway includes ATM, for instance, is mutated in Ataxia telangiectasia
patients (AT) that suffer from an increased incidencethe putative S phase–specific DNA damage sensor
Rfc5p, the precursor lesion is probably a product of of leukemia and lymphoma. Cells from AT patients are
hypersensitive to DSB inducing agents and show in-DNA replication. This is most likely to be DNA ends that
arise as a consequence of stalled or collapsed DNA creased chromosomal aberration as well as a failure to
induce a DNA damage response. The ATM-mediatedreplication forks (Haber, 1999). Regarding the relevant
signaling endpoint, I think the study provides some inter- DNA damage response consists of phosphorylation of
key components of cell cycle checkpoints including p53,esting clues. First, RFC5, MEC1, and DUN1 appear to
belong to the same pathway for suppression of chromo- BRCA1, CHK2, and NBS1 (reviewed in Rotman and Shi-
loh, 1999). The related human protein kinase ATR inter-somal aberrations. Unlike Rfc5p and Mec1p, Dun1p is
not known to be required for DNA damage–dependent acts functionally with BRCA1 in a manner that suggests
parallel action of ATM and ATR to enforce cell cycleS phase arrest. Thus, the cell cycle arrest subroutine
of the checkpoint may not be a primary contributor to checkpoints in response to distinct forms of DNA dam-
age (Tibbetts et al., 2000). In mice, the loss of ATR ischromosomal stability as measured by this assay. In-
stead, DNA damage signaling might be required for the lethal. Homozygous Atr2/2 embryos die early in develop-
ment as a consequence of extensive apoptosis and theregulation of DNA repair activities to coordinate individ-
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Hartwell, L.H., and Kastan, M.B. (1994). Science 266, 1821–1828.cells from such embryos exhibit high levels of chromo-
Jiricny, J. (1998). EMBO J. 17, 6427–6436.somal aberrations (Brown and Baltimore, 2000).
Johnson, R.D., and Jasin, M. (2000). EMBO J. 19, 3398–3407.Mutations in human NBS1 underlie the AT-related Nij-
megen breakage syndrome, a condition that is character- Lengauer, C., Kinzler, K.W., and Vogelstein, B. (1998). Nature 396,
643–649.ized by ionizing-irradiation sensitivity, a failure to arrest
Lim, D.S., Kim, S.T., Xu, B., Maser, R.S., Lin, J., Petrini, J.H., andthe cell cycle at G1/S in response to DNA damage, chro-
Kastan, M.B. (2000). Nature 404, 613–617.mosomal instability, and cancer predisposition (Carney et
Lindahl, T., and Barnes, D.E. (1992). Annu. Rev. Biochem. 61,al., 1998). The similarity of this syndrome to AT sug-
251–281.gested that the underlying genetic defects might be
Mitelman, F., Johansson, B., and Mertens, F. (1994). Catalog ofrelated, and this was confirmed by the finding that ATM
Chromosome Aberrations in Cancer. (New York: Willey-Liss).phosphorylates NBS1 in response to DNA damage (Lim
Myung, K., Datta, A., and Kolodner, R.D. (2001). Cell 104, this issue,et al., 2000). NBS1 is an ortholog of yeast Xrs2p and is
397–408.
part of the human MRE11-RAD50-NBS1 complex. The
Paulovich, A.G., Toczyski, D.P., and Hartwell, L.H. (1997). Cell 88,
discovery of mutations in human MRE11 causing yet 315–321.
another AT-like disorder (ATLD) substantiated the idea
Rotman, G., and Shiloh, Y. (1999). Oncogene 18, 6135–6144.
that ATM-NBS-mediated DNA damage signaling in hu-
Tibbetts, R.S., Cortez, D., Brumbaugh, K.M., Scully, R., Livingston,
mans involves the entire MRE11 complex, and that a D., Elledge, S.J., and Abraham, R.T. (2000). Genes Dev. 14, 2989–
failure of this pathway can result in chromosome insta- 3002.
bility and cancer. Wang, Y., Cortez, D., Yazdi, P., Neff, N., Elledge, S.J., and Qin, J.
Mutations in BRCA1 and BRCA2 predispose women (2000). Genes Dev. 14, 927–939.
to an increased risk of breast cancer and are also ass-
ociated with high levels of chromosomal abnormalities.
The DNA damage–induced functional interaction of ATM
and ATR with BRCA1, and the coexistence in a super-
protein complex of BRCA1 with ATM, the MRE11-
RAD50-NBS1 complex, the mismatch repair proteins
MSH2 and MSH6, and the Bloom’s helicase BLM (Wang
et al., 2000) suggest that the chromosomal abnormalities
found in BRCA1 and BRCA2 tumors may also result
from a failure of ATM/ATR dependent checkpoints.
Conclusion
These selected examples illustrate that DNA damage
checkpoints form an integral part of the cellular defense
against chromosome instability and may help to avoid
cancer. The general principle seems established, but
where do we go from here? Quite clearly, back to sorting
out the details. A major limitation to genetic dissections
of DNA damage signaling pathways is the pleiotropic
nature of checkpoint defects and the functional ambigu-
ity of factors acting at the interfaces between DNA dam-
age sensing, signaling, and repair. A combination of
genetics and biochemistry will be needed to unravel
the general architecture of the network of interacting
checkpoint pathways on the one side and to explore the
rules of communication between DNA damage signaling
and repair factors on the other side. Thus, there is plenty
of fascinating work ahead.
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